Robert S Benjamin Selected Research

Robert S Benjamin Research Topics

Disease

68	Neoplasms (Cancer) 02/2024 - 06/2002
55	Sarcoma (Soft Tissue Sarcoma) 01/2023 - 09/2002
28	Gastrointestinal Stromal Tumors (Gastrointestinal Stromal Tumor) 01/2023 - 12/2003
11	Ewing Sarcoma (Sarcoma, Ewing) 07/2020 - 02/2007
11	Osteosarcoma (Osteogenic Sarcoma) 01/2020 - 01/2002
9	Disease Progression 01/2022 - 03/2003
7	Cardiotoxicity 01/2021 - 12/2004
5	Aggressive Fibromatosis (Desmoid) 08/2012 - 01/2006
5	Necrosis 01/2009 - 07/2004
4	Melanoma (Melanoma, Malignant) 01/2017 - 04/2002
3	Hemangiosarcoma (Angiosarcoma) 01/2022 - 12/2005
3	Rhabdomyosarcoma 01/2020 - 11/2007
3	Breast Neoplasms (Breast Cancer) 05/2017 - 12/2005
3	Hemorrhage 01/2016 - 06/2002
3	Leiomyosarcoma 01/2016 - 06/2003
3	Myxoid Liposarcoma 12/2012 - 03/2008
3	Neoplasm Metastasis (Metastasis) 10/2012 - 07/2002
3	Synovial Sarcoma (Synovioma) 07/2009 - 11/2007
2	Liposarcoma 01/2023 - 07/2009
2	Desmoplastic Small Round Cell Tumor 10/2018 - 01/2018
2	Giant Cell Tumor of Bone 01/2015 - 09/2003
2	Solitary Fibrous Tumors 05/2013 - 11/2011
2	Fever (Fevers) 01/2010 - 06/2006
2	Neutropenia 01/2010 - 06/2006
2	Fibrosarcoma 07/2009 - 11/2003
2	Margins of Excision 01/2006 - 05/2003
2	Thrombocytopenia (Thrombopenia) 08/2003 - 03/2003
2	Lymphoma (Lymphomas) 03/2003 - 06/2002
1	Wounds and Injuries (Trauma) 12/2022
1	Phyllodes Tumor (Cystosarcoma Phylloides) 04/2021
1	Prostatic Neoplasms (Prostate Cancer) 01/2019
1	Warts (Wart) 10/2018
1	Airway Obstruction (Choking) 05/2017
1	Asphyxia (Suffocation) 05/2017
1	Giant Cell Tumors (Giant Cell Tumor) 05/2017
1	Ependymoma 04/2015

Drug/Important Bio-Agent (IBA)

27	Imatinib Mesylate (Gleevec)FDA Link 07/2017 - 03/2003
18	Doxorubicin (Adriamycin)FDA LinkGeneric 01/2021 - 01/2002
11	Ifosfamide FDA LinkGeneric 04/2021 - 09/2002
6	Gemcitabine FDA Link 01/2023 - 07/2007
5	Biomarkers (Surrogate Marker)IBA 01/2023 - 01/2008
5	AnthracyclinesIBA 01/2020 - 12/2004
4	Docetaxel (Taxotere)FDA Link 01/2023 - 07/2007
4	pazopanib FDA Link 01/2020 - 11/2017
4	Cisplatin (Platino)FDA LinkGeneric 10/2018 - 07/2004
4	Phosphotransferases (Kinase)IBA 08/2009 - 09/2004
3	thiamine triphosphorate (TTP)IBA 07/2011 - 05/2007
3	Receptor Protein-Tyrosine Kinases (Tyrosine Kinase Receptors)IBA 02/2008 - 01/2006
2	Dexrazoxane (Zinecard)FDA LinkGeneric 01/2021 - 02/2014
2	Methotrexate (Mexate)FDA LinkGeneric 01/2020 - 01/2009
2	CytokinesIBA 01/2018 - 04/2002
2	Trastuzumab (Herceptin)FDA Link 11/2017 - 12/2004
2	Mitogen-Activated Protein Kinase Kinases (MEKs)IBA 11/2017 - 01/2014
2	Vincristine (Oncovin)FDA LinkGeneric 10/2017 - 01/2015
2	Denosumab FDA Link 05/2017 - 01/2015
2	Hemoglobins (Hemoglobin)IBA 01/2016 - 01/2010
2	InterferonsIBA 01/2015 - 08/2012
2	Platelet-Derived Growth Factor Receptors (Platelet-Derived Growth Factor Receptor)IBA 06/2014 - 07/2011
2	Insulin-Like PeptidesIBA 12/2011 - 10/2006
2	Temozolomide (Temodar)FDA LinkGeneric 11/2011 - 12/2003
2	Vascular Endothelial Growth Factor A (Vascular Endothelial Growth Factor)IBA 07/2011 - 11/2007
2	DNA (Deoxyribonucleic Acid)IBA 10/2010 - 02/2008
2	Fluorodeoxyglucose F18 (Fludeoxyglucose F 18)FDA Link 01/2008 - 05/2007
2	Platelet-Derived Growth Factor beta Receptor (Receptor, Platelet Derived Growth Factor beta)IBA 11/2007 - 07/2005
2	Indicators and Reagents (Reagents)IBA 12/2004 - 03/2003
1	ripretinibIBA 02/2024
1	avapritinibIBA 02/2024
1	pembrolizumabIBA 01/2022
1	IGF Type 1 Receptor (IGF 1 Receptor)IBA 07/2020
1	AntibodiesIBA 07/2020
1	RNA (Ribonucleic Acid)IBA 01/2020
1	Proteins (Proteins, Gene)FDA Link 01/2020
1	T-Cell Antigen Receptors (T-Cell Receptor)IBA 01/2020
1	Immune Checkpoint InhibitorsIBA 01/2020
1	RadiumIBA 01/2019
1	ST 679IBA 12/2017
1	Lapatinib (GW572016)FDA Link 11/2017
1	Vorinostat FDA Link 11/2017
1	Histone Deacetylases (Histone Deacetylase)IBA 11/2017
1	Everolimus FDA Link 11/2017
1	Brain Natriuretic Peptide (Natrecor)FDA Link 01/2017
1	Endothelin-3 (Endothelin 3)IBA 01/2017
1	TroponinIBA 01/2017
1	TOR Serine-Threonine KinasesIBA 12/2016
1	Somatomedin Receptors (Somatomedin Receptor)IBA 12/2016
1	Drug CombinationsIBA 12/2016

Therapy/Procedure

45	Therapeutics 01/2023 - 01/2002
31	Drug Therapy (Chemotherapy) 04/2021 - 04/2002
18	Radiotherapy 12/2022 - 05/2003
6	Neoadjuvant Therapy 01/2020 - 09/2002
4	Adjuvant Chemotherapy 05/2017 - 11/2003
3	Immunotherapy 01/2022 - 07/2012
3	Aftercare (After-Treatment) 01/2007 - 12/2004
2	Combination Drug Therapy (Combination Chemotherapy) 12/2017 - 12/2004
2	Platelet Transfusion (Blood Platelet Transfusions) 03/2003 - 06/2002
1	Investigational Therapies (Experimental Therapy) 01/2023
1	Hyperthermic Intraperitoneal Chemotherapy 10/2018
1	Cytoreduction Surgical Procedures 10/2018
1	Tracheostomy 05/2017
1	Combined Modality Therapy 01/2016